Harnessing crispr-cas to combat covid-19: From diagnostics to therapeutics
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global threat with an ever-increasing death toll even after a year on. Hence, the rapid identification of infected individuals with diagnostic tests continues to be crucial in t...
Published in: | Life |
---|---|
Main Author: | Chan K.G.; Ang G.Y.; Yu C.Y.; Yean C.Y. |
Format: | Review |
Language: | English |
Published: |
MDPI
2021
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118994920&doi=10.3390%2flife11111210&partnerID=40&md5=9666d187313d27088d6813d2441a934a |
Similar Items
-
The Current Landscape of CRISPR-Cas9-based Technologies for Imaging of Genomic Loci in Fixed and Live Cells
by: Yu C.Y.; Yean C.Y.; Chan K.G.; Ang G.Y.
Published: (2024) -
Nucleic acid-based diagnostic tests for the detection SARS-CoV-2: An update
by: Yu C.Y.; Chan K.G.; Yean C.Y.; Ang G.Y.
Published: (2021) -
Lateral Flow Immunoassays for SARS-CoV-2
by: Ang G.Y.; Chan K.G.; Yean C.Y.; Yu C.Y.
Published: (2022) -
Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody
by: Cheong W.S.; Leow C.Y.; Abdul Majeed A.B.; Leow C.H.
Published: (2020) -
The Construction of CRISPR-Cas9 System Targeting Vector for CYP3A4 Gene in Hepatic Cell Lines
by: Hatta F.H.M.; Aziz F.N.A.; Rehman S.-U.; Othman A.A.
Published: (2025)